THE ROLE OF THE CLINICAL PHARMACIST IN OPTIMIZING DRUG THERAPY
Abstract
This article provides a comprehensive analysis of the clinical pharmacist's role in the modern healthcare system, their responsibilities in the drug therapy optimization process, and the positive impact they have on patient health outcomes. Clinical pharmacy is a contemporary discipline that has emerged at the intersection of pharmaceutical science and clinical medicine, ensuring the safe, effective, and economically rational use of medications in collaboration with physicians, nurses, and other healthcare professionals. It has been scientifically demonstrated that the active involvement of clinical pharmacists in global healthcare practice reduces the incidence of adverse drug reactions (ADRs) by 45–66%, shortens hospital stays, and significantly decreases overall treatment costs. The article discusses the problem of polypharmacy, drug-drug interactions, medication adherence, and the specific mechanisms through which clinical pharmacists address these challenges. In conclusion, the article emphasizes that developing the field of clinical pharmacy and implementing it broadly into practice is one of the priority tasks of the modern healthcare system.
References
1. World Health Organization. (2019). Medication Without Harm: WHO Global Patient Safety Challenge. Geneva: WHO Press.
2. Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17(1), 230. https://doi.org/10.1186/s12877-017-0621-2
3. Cheung, K. C., Bouvy, M. L., & De Smet, P. A. G. M. (2009). Medication errors: the importance of safe dispensing. British Journal of Clinical Pharmacology, 67(6), 676–680.
4. Johansson, T., Abuzahra, M. E., Keller, S., et al. (2016). Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis. British Journal of Clinical Pharmacology, 82(2), 532–548.
5. Santschi, V., Chiolero, A., Colosimo, A. L., et al. (2014). Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. Journal of the American Heart Association, 3(2), e000718.
6. Spinewine, A., Schmader, K. E., Barber, N., et al. (2007). Appropriate prescribing in elderly people: how well can it be measured and optimised? The Lancet, 370(9582), 173–184.
7. Pharmaceutical Society of Australia. (2020). Medicine Management in Aged Care: Summary Paper. PSA: Canberra.
8. International Pharmaceutical Federation (FIP). (2021). Clinical Pharmacy: FIP Statements of Policy. The Hague: FIP.
9. Viktil, K. K., Blix, H. S., Moger, T. A., & Reikvam, A. (2007). Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. British Journal of Clinical Pharmacology, 63(2), 187–195.
10. Kaboli, P. J., Hoth, A. B., McClimon, B. J., & Schnipper, J. L. (2006). Clinical pharmacists and inpatient medical care: a systematic review. Archives of Internal Medicine, 166(9), 955–964.
